Silo Pharma Inc (SILO) - News Archive

Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company committed to innovating drug delivery systems and formulations, is making waves across different sectors of the healthcare and technology...

In a significant development reflecting a broader trend among corporations, Silo Pharma Inc. has taken a bold step toward financial diversification by approving a purchase of $1 million in Bitcoin as a treasury reserve...

In recent developments within the realm of chronic pain management, Silo Pharma, a biopharmaceutical company dedicated to the development of innovative therapeutic solutions, has announced an expansion of its developmen...

In recent news, Silo Pharma Inc. (NASDAQ: SILO), a developmental-stage biopharmaceutical company, has announced its entry into a $2.1 million Registered Direct Offering. This move marks a significant milestone for the c...

Silo Pharma Advancing Research and Development with $2.1 Million Registered Direct OfferingSarasota, FL - Silo Pharma, Inc. (Nasdaq: SILO), a prominent biopharmaceutical company specializing in innovative drug delivery...

Year to date, Silo Pharma Inc. (NASDAQ: SILO) has witnessed a lackluster performance, falling short of the overall market s 18.4% gain. However, recent developments have catapulted the company into the spotlight, as it...

Silo Pharma Inc., a renowned pharmaceutical company, has recently secured an exclusive global license for a groundbreaking Alzheimer s therapeutic. This agreement is set to significantly bolster the company s intellectu...

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and AnxietySarasota-based biopharmaceutical company, Silo Pharma, has recently announced a partnership with AmplifyBio to advance the development of their...

Sarasota-based Silo Pharma, a developmental stage biopharmaceutical company specializing in novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, recently announced a sign...

Silo Pharma Advances PTSD and Anxiety Treatment with FDA Pre-IND Submission Report on Latest Developments Biopharmaceutical firm Silo Pharma Inc. has recently made significant strides in the development of innovative tr...

CSIMarket.com presents an overview of Silo Pharma s participation in an FDA meeting, where the company explores the evolving therapeutic interest in ketamine, particularly pertaining to their developmental drug Silos SP...

Silo Pharma s Intranasal PTSD Treatment Shows Promising Results: Revolutionizing Therapy DeliveryIn recent years, the field of mental health has witnessed revolutionary advancements in the treatment of Post-Traumatic St...

Silo Pharma Secures Exclusive License for Innovative Therapeutic Targeting PTSD and Stress-Induced Anxietyp align=centeremExclusive license for development, manufacturing, and commercialization in process/em/pThe search...

Silo Pharma Enters Exclusive License Agreement with MedSpray Pharma BV for Innovative PTSD TreatmentSilo Pharma Inc, a prominent pharmaceutical company, recently announced its exclusive license agreement with MedSpray P...